According to the research report titled ‘Global Smoking Cessation Aids Market Size study, by Product (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes, Others) by End User (Hospital Pharmacies, Online Channel, Retail Pharmacies, Others) and Regional Forecasts 2021-2027,’ available with MarketStudyReport, global smoking cessation aids market is expected to progress at 12.5% CAGR during the period 2021-2027.
 

The massive population habitual to smoking, coupled with various anti-smoking campaigns started by NGOs & government authorities across the world are factors contributing effectively to the growth of global smoking cessation aids market. 
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4219590/
 

In this context, World Health Organization (WHO) reported in its 2021 factsheet that more than 1.3 billion people across the globe consumed tobacco, wherein most consumption was in the form of smoking.
 

For those unaware, smoking cessation aids are products that are intended to facilitate a person in quitting their smoking habits by substituting it with non-harmful routines such as chewing nicotine gum and using e-cigarettes.
 

There are numerous companies involved in spreading awareness about the harmful effects of inhaling tobacco, which is creating lucrative prospects for the businesses in this line of work. 
 

Despite the positive outlook, the huge development costs of de-addiction therapies and nicotine replacement products is likely to hamper the progress of the industry in the forthcoming years. 
 

Based on product type, worldwide smoking cessation aids market is categorized into electronic cigarettes, drugs, nicotine replacement therapy, and others. In terms of end-user ambit, the industry is segregated into online channels, retail pharmacies, hospital pharmacies, and others. 
 

From a regional standpoint, Asia Pacific market is poised to account for a considerable revenue share as well as witness a significant growth rate during the assessment timeline, due to the soaring disposable income of individual, increasing awareness about de-addiction products, and various government programs to increase awareness about the lethal effects of smoking among masses. 
 

The prominent players in global smoking cessation aids industry are Dr. Reddy's Laboratories Limited, NJOY, Inc., Takeda Pharmaceutical Co. Ltd., Pfizer, Inc., Cipla Limited, GlaxoSmithKline plc, Bayer AG, F. Hoffmann-La Roche AG, Johnson & Johnson, and Novartis International AG among others.